Furosemide Tablets Solicitation

This government file, likely an amendment or modification to an existing solicitation or contract, outlines key requirements for submitting offers. It specifies that offers must be received by a particular date and time, highlighting the importance of adherence to deadlines. The document details methods for submission, including mail, hand-delivery, or electronic submission, emphasizing that offers not received by the specified time will be considered late. It also addresses amendments to the solicitation, stating that all terms and conditions remain unchanged unless explicitly modified. Furthermore, it requires offerors to acknowledge receipt of amendments, often by signing and returning copies. The file underscores that all provisions and clauses referenced in the document are incorporated by reference. The purpose of this file is to ensure offerors are fully aware of submission protocols and any changes to the original solicitation, maintaining fairness and compliance in the procurement process.

The Defense Logistics Agency (DLA) Troop Support is seeking a national contract for pharmaceutical products, specifically Furosemide in various dosages and bottle counts (20 MG, 40 MG, and 80 MG tablets). This solicitation (SPE2D2-26-R-0005) aims to establish a supply source for DLA and VA customers through their Pharmaceutical Prime Vendor (PPV) programs, including the Indian Health Service and Bureau of Prisons. The contract will have a one-year base period and four option years, totaling a maximum of five years. Offerors must submit proposals electronically via the DIBBS system by May 21, 2026, and adhere to strict requirements including product registration, bar code labeling, therapeutic equivalence, and FDA approvals for manufacturing facilities. Special considerations include business-to-business agreements with PPV contractors for payments and addressing potential backorders.